{"SPADE_UN_15641": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15641", "Peptide Name": "AMP1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "WKWLKKWIK", "Sequence Length": 9, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:OVCAR-3 (IC50=51.1 ÂµM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C69H102N16O10", "Mass": 1315.65, "PI": 10.48, "Net Charge": 4, "Hydrophobicity": -1.11, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers", "Pubmed ID": "33184577", "Reference": "Cell Mol Bioeng. 2020 Jun 24;13(5)447-461.", "Author": "Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33184577"}, {"Title": "Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides", "Pubmed ID": "", "Author": "Ramon-Garcia S, Mikut R, ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ"}], "Frequent Amino Acids": "KWI", "Absent Amino Acids": "ACDEFGHMNOPQRSTUVY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 4, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03606", "Similarity": 1.0, "Sequence": "AKRLKKLAKKIWKWL"}, {"SPADE_ID": "SPADE_N_11507", "Similarity": 1.0, "Sequence": "WKWKWKPGKWKWKW"}, {"SPADE_ID": "SPADE_N_13039", "Similarity": 1.0, "Sequence": "FKLKLKFSNKLKWKW"}]}}}